Acadia Healthcare (NASDAQ:ACHC) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Acadia Healthcare (NASDAQ:ACHC) posted its quarterly earnings data on Tuesday. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03, Zacks reports. The company had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 5.95%. The firm’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.83 earnings per share. Acadia Healthcare updated its FY 2026 guidance to 1.450-1.600 EPS.

Acadia Healthcare Price Performance

Shares of ACHC stock traded up $0.46 during trading hours on Thursday, reaching $27.81. The company had a trading volume of 834,630 shares, compared to its average volume of 3,356,934. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The company has a market capitalization of $2.56 billion, a price-to-earnings ratio of -2.23, a PEG ratio of 10.90 and a beta of 0.64. The stock has a fifty day moving average of $28.00 and a 200-day moving average of $23.59.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Wellington Management Group LLP boosted its position in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after buying an additional 2,350,760 shares during the period. Goldman Sachs Group Inc. increased its holdings in Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. UBS Group AG boosted its stake in shares of Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares during the period. State Street Corp raised its holdings in Acadia Healthcare by 3.3% in the fourth quarter. State Street Corp now owns 3,293,951 shares of the company’s stock valued at $46,741,000 after acquiring an additional 104,715 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Acadia Healthcare by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 1,633,192 shares of the company’s stock worth $23,181,000 after acquiring an additional 7,453 shares during the last quarter.

Wall Street Analyst Weigh In

ACHC has been the subject of several research analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Guggenheim boosted their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday. KeyCorp increased their target price on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. UBS Group raised their target price on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.